Xtant Medical Holdings, Inc. XTNT
Set alert
0.28 USD 0.00 -0.64%
At close · Nov 2
0.28 0.00 -0.04%
After hours · Nov 2, 5:59 PM ET
0.2783 Day range 0.3115
0.27 52-week range 0.89
- YTD
- -64.31%
- 1 year
- -68.36%
- Open
- 0.33
- Prev close
- 0.2802
- Mkt cap
- 39.06M
- Vol
- 264.95K
- Avg vol
- 1.69M
- EPS
- -0.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2783
- High
- 0.3115
- Forward P/E
- -13.43
- Beta
- 0.39
- Short ratio
- 6.92
- Inst. own
- 65.12%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.467
- 200-d avg
- 0.68755
- 1y target
- 2.25
3M chart
Signals (18)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
Financial health
Altman Z-Score
-2.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E 19.6×
FY 2016 5y median -3.7× FY 2025
P/S 0.8×
FY 2016 5y median 0.9× FY 2025
P/B 2.1×
FY 2016 5y median 1.8× FY 2025
P/FCF 10.8×
FY 2016 5y median -8.7× FY 2025
EV/EBITDA 7.6×
FY 2016 5y median -10.8× FY 2025
EV/Sales 0.9×
FY 2016 5y median 0.9× FY 2025
FCF Yield 9.3%
FY 2016 5y median -8.2% FY 2025
Profitability
Gross Margin 62.9%
FY 2016 5y median 58.8% FY 2025
Operating Margin 5.4%
FY 2016 5y median -10.3% FY 2025
Net Margin 3.7%
FY 2016 5y median -8.8% FY 2025
ROE 9.8%
FY 2016 5y median -15.7% FY 2025
ROIC 6.5%
FY 2016 5y median -8.1% FY 2025
ROA 5.3%
FY 2016 5y median -8.9% FY 2025
Growth (YoY)
Revenue 14.2%
FY 2016 FY 2025
Operating Income 160.3%
FY 2016 FY 2025
EPS (diluted) 125.0%
FY 2016 FY 2025
Free Cash Flow 163.5%
FY 2016 FY 2025
Financial Health
Current Ratio 2.7×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 1.6×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 0.7×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 2.0×
FY 2016 5y median -3.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
